Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irama Villar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|October 3, 2014
Dr. Erdozain, et al replyJose Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2005
Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicityFernando Perez-Ruiz, Iñaki Hernando, Irama Villar, et al.
The Journal of Rheumatology|January 17, 2014
Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factorsJose Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
The Journal of Rheumatology|December 17, 2014
Prevalence and significance of persistently positive antiphospholipid antibodies in women with preeclampsiaCristina Gonzalez-Echavarri, Irama Villar, Amaia Ugarte, et al.
Autoimmunity Reviews|July 31, 2012
Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategyGuillermo Ruiz-Irastorza, Maider Garmendia, Irama Villar, et al.
Lupus Science & Medicine|January 27, 2017
Predictors of peripheral arterial disease in SLE change with patient's ageJose-Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
Autoimmunity Reviews|November 6, 2013
Prednisone in lupus nephritis: how much is enough?Guillermo Ruiz-Irastorza, Alvaro Danza, Isabel Perales, et al.
Plos One|January 29, 2016
LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA CarriersEguzkine Ochoa, Mikel Iriondo, Carmen Manzano, et al.
Lupus|September 27, 2007
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosusAgustin Martinez-Berriotxoa, Guillermo Ruiz-Irastorza, Maria-Victoria Egurbide, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Ankle-brachial index and arterial vascular events in systemic lupus erythematosus patients: a 5-year prospective cohortJose-Gabriel Erdozain, Jose-Ignacio Pijoan, Irama Villar, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|October 3, 2014
Dr. Erdozain, et al replyJose Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2005
Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicityFernando Perez-Ruiz, Iñaki Hernando, Irama Villar, et al.
The Journal of Rheumatology|January 17, 2014
Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factorsJose Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
The Journal of Rheumatology|December 17, 2014
Prevalence and significance of persistently positive antiphospholipid antibodies in women with preeclampsiaCristina Gonzalez-Echavarri, Irama Villar, Amaia Ugarte, et al.
Autoimmunity Reviews|July 31, 2012
Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategyGuillermo Ruiz-Irastorza, Maider Garmendia, Irama Villar, et al.
Lupus Science & Medicine|January 27, 2017
Predictors of peripheral arterial disease in SLE change with patient's ageJose-Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
Autoimmunity Reviews|November 6, 2013
Prednisone in lupus nephritis: how much is enough?Guillermo Ruiz-Irastorza, Alvaro Danza, Isabel Perales, et al.
Plos One|January 29, 2016
LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA CarriersEguzkine Ochoa, Mikel Iriondo, Carmen Manzano, et al.
Lupus|September 27, 2007
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosusAgustin Martinez-Berriotxoa, Guillermo Ruiz-Irastorza, Maria-Victoria Egurbide, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Ankle-brachial index and arterial vascular events in systemic lupus erythematosus patients: a 5-year prospective cohortJose-Gabriel Erdozain, Jose-Ignacio Pijoan, Irama Villar, et al.
Pageof 2